Results 61 to 70 of about 114,754,979 (236)

Microbial communities and functional diversity in seafood

open access: yesJSFA reports, EarlyView.
Abstract Functional diversity encompasses ecosystem processes that enhance adaptability to environmental change. This study explores the diversity of microorganisms associated with seafood. In this paper, we present our knowledge of microbial diversity in relation to seafood.
Christian Larbi Ayisi   +3 more
wiley   +1 more source

Antibodies and Vaccines Against Botulinum Toxins: Available Measures and Novel Approaches

open access: yes, 2019
International audienceBotulinum neurotoxin (BoNT) is produced by the anaerobic, Gram-positive bacterium Clostridium botulinum. As one of the most poisonous toxins known and a potential bioterrosism agent, BoNT is characterized by a complex mode of action
Rasetti-Escargueil, Christine   +3 more
core   +1 more source

Comparison of anterior versus posterior inferior turbinate botulinum toxin type A injections in refractory chronic rhinitis: a randomized, single-blind study

open access: yesThe Egyptian Journal of Otolaryngology
Background Refractory chronic rhinitis often persists despite standard medical therapy. Botulinum toxin type A (BTX-A) injection into the inferior turbinates offers a minimally invasive alternative, but the influence of the injection site within the ...
Alireza Mohebbi   +3 more
doaj   +1 more source

Cervical Inlet Patches in R‐CPD: An Unrecognized Predictor of Treatment Failure

open access: yesThe Laryngoscope, EarlyView.
This retrospective cohort study identified cervical inlet patches (CIP) in 19.8% of patients undergoing cricopharyngeal botulinum toxin injection for R‐CPD. CIP presence and increasing age independently predicted failure to sustain a long‐term treatment response, suggesting that CIP may be an underrecognized factor in R‐CPD treatment durability ...
Andrew Geoffrey Tritter   +2 more
wiley   +1 more source

Capsaicin protects neuromuscular junctions from the inhibitory effects of botulinum neurotoxin A [PDF]

open access: yes, 2008
Within 24 hrs after injecting botulinum neurotoxin A (BoNT/A) into the hindlimb, mice lost the toe spread reflex and developed progressive muscle weakness. At the same time, the compound muscle action potential amplitude decreased. Injection of capsaicin
Carmen Garcia   +5 more
core  

The Effectiveness of Botulinum Toxin Type A Injections in the Management of Sialorrhea [PDF]

open access: yes, 2018
Objective: The aim of this study was to evaluate the effect of Botulinum toxin type A by injecting in the submandibular and parotid glands on the frequency and severity of sialorrhea.Methods: Pediatric patients who were referred to our department with ...
Özgür Tarkan   +6 more
core   +1 more source

Botulinum toxin type A on cutaneous flap viability in diabetic and tobacco-exposed rats [PDF]

open access: yesActa Cirúrgica Brasileira, 2015
PURPOSE:To investigate the effect of Botulinum toxin A (BoNTA) on skin flap viability in healthy, tobacco-exposed and diabetic rats.METHODS: Ninety male Wistar rats (250-300g) were randomly divided into six groups: control+saline (C1), control+BoNTA (C2),
Cristina Pires Camargo   +7 more
doaj   +1 more source

Measuring Effects on Pain and Quality of Life after Abobotulinum Toxin A Injections in Children with Cerebral Palsy

open access: yesToxins, 2022
Sixty-seven percent of children with cerebral palsy (CCP) experience pain. Pain is closely interrelated to diminished quality of life. Despite this, pain is an overlooked and undertreated clinical problem.
Christian Wong   +2 more
doaj   +1 more source

Supraglottic Botulinum Toxin Injection Improves Symptoms of Laryngeal Sensory Dysfunction

open access: yesThe Laryngoscope, EarlyView.
In this retrospective cohort of 80 patients with refractory laryngeal sensory symptoms, supraglottic botulinum toxin type A significantly improved Laryngeal Hypersensitivity Questionnaire, Reflux Symptom Index, and Cough Severity Index scores at a mean of 5.2 weeks, while Voice Handicap Index‐10 scores remained unchanged.
Daniel Novakovic   +3 more
wiley   +1 more source

Intravesical Injection of Botulinum Toxin Type A in Patients with Refractory Overactive Bladder—Results between Young and Elderly Populations, and Factors Associated with Unfavorable Outcomes

open access: yesToxins, 2023
Intravesical botulinum toxin type A (BoNT-A) injection has been recognized as the standard treatment for refractory overactive bladder (OAB). However, its therapeutic efficacy and safety have not been thoroughly reviewed in elderly patients.
Yin-Chien Ou   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy